| Half-life | 13 hours |
| Clearance Route | mixed |
| Active Metabolites | no |
| Notes | Half-life primarily reflects olmesartan component. |
Severity: Moderate
Adverse Effects:
Hypotension, dizziness, hyperuricemia, hyperkalemia
Contraindications:
Pregnancy, anuria, severe renal impairment
Precautions:
Monitor potassium and renal function